Early deficits in an in vitro striatal microcircuit model carrying the Parkinson's GBA-N370S mutation.
Do QB. et al, (2024), NPJ Parkinsons Dis, 10
Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons.
Beccano-Kelly DA. et al, (2023), iScience, 26
Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model.
Ciceri D. et al, (2023), J Vis Exp
REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
Ryan BJ. et al, (2021), J Neurosci, 41, 3731 - 3746
Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
Bengoa-Vergniory N. et al, (2021), Acta Neuropathol Commun, 9
GABA uptake transporters support dopamine release in dorsal striatum with maladaptive downregulation in a parkinsonism model.
Roberts BM. et al, (2020), Nat Commun, 11
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease.
Bengoa-Vergniory N. et al, (2020), Nat Commun, 11
Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
Butkovich LM. et al, (2020), J Neurosci, 40, 7559 - 7576
Understanding the pathophysiological role of early tau aggregates in Alzheimer's disease by their direct visualisation in situ
Velentza-Almpani E. et al, (2020), NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 46, 42 - 42
Selective vulnerability in α-synucleinopathies.
Alegre-Abarrategui J. et al, (2019), Acta Neuropathol, 138, 681 - 704
Impairment of Macroautophagy in Dopamine Neurons Has Opposing Effects on Parkinsonian Pathology and Behavior.
Hunn BHM. et al, (2019), Cell Rep, 29, 920 - 931.e7
Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
Zambon F. et al, (2019), Hum Mol Genet, 28, 2001 - 2013
Alpha-Synuclein Proximity Ligation Assay (AS-PLA) in Brain Sections to Probe for Alpha-Synuclein Oligomers.
Roberts RF. et al, (2019), Methods Mol Biol, 1948, 69 - 76
Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease.
Fields CR. et al, (2019), Front Mol Neurosci, 12
Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
Ruffmann C. et al, (2018), Neuropathol Appl Neurobiol, 44, 722 - 736
Alpha-synuclein oligomers: a new hope.
Bengoa-Vergniory N. et al, (2017), Acta Neuropathol, 134, 819 - 838
Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo.
McMillan KJ. et al, (2017), Mol Ther, 25, 2404 - 2414
Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy.
Wobst HJ. et al, (2017), Sci Rep, 7